A score predicting survival after liver retransplantation for hepatitis C virus cirrhosis

Transplantation

Volumn 93, Issue 7, 2012, Pages 717-722

  Andres, Axel ^a   Gerstel, Eric ^a   Combescure, Christophe ^a   Asthana, Sonal ^b   Merani, Shaheed ^b   Majno, Pietro ^a   Berney, Thierry ^a   Morel, Philippe ^a   Kneteman, Norman ^b   Mentha, Gilles ^a   Toso, Christian ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Hepatitis C; Liver transplantation; Retransplantation; Score; Survival

Indexed keywords

CREATININE; SERUM ALBUMIN;

AGE; ALBUMIN BLOOD LEVEL; ANALYTICAL PARAMETERS; ARTICLE; CREATININE BLOOD LEVEL; DONOR AGE; FEMALE; HEPATITIS C; HUMAN; INTERNATIONAL NORMALIZED RATIO; INTERVAL BETWEEN BOTH TRANSPLANTATIONS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RECIPIENT AGE; REGISTER; RETRANSPLANTATION; SCORING SYSTEM; SURVIVAL PREDICTION;

ADULT; FEMALE; GRAFT REJECTION; HEPATITIS C, CHRONIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGISTRIES; REOPERATION; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SWITZERLAND; TIME FACTORS; WAITING LISTS;

EID: 84859268298     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318246f8b3     Document Type: Article

References (33)

1. The 2009 Annual Report of the OPTN and SRTR: Transplant Data 1999-2008.Available at: http://www.ustransplant.org/annual-reports/current/. Accessed July 10, 2011
2. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992; 103: 317
3. Aytaman A, Kaufman M, Terrault NA. Management of posttransplant hepatitis C infection. Curr Opin Organ Transplant 2010; 15: 301
4. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: Increase in recent years. J Hepatol 2000; 32: 673
5. Gane EJ. The natural history of recurrent hepatitis C and what influences this. Liver Transpl 2008; 14(suppl 2): S36
6. Carrion JA, Navasa M, Forns X. Retransplantation in patients with hepatitis C recurrence after liver transplantation. J Hepatol 2010; 53: 962
7. Pelletier SJ, Schaubel DE, Punch JD, et al. Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl 2005; 11: 434
8. Yoo HY, Maheshwari A, Thuluvath PJ. Retransplantation of liver: Primary graft nonfunction and hepatitis C virus are associated with worse outcome. Liver Transpl 2003; 9: 897
9. Ghobrial RM, Gornbein J, Steadman R, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 2002; 236: 315
10. Berenguer M, Prieto M, Palau A, et al. Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis. Liver Transpl 2003; 9: 228
11. Yao FY, Saab S, Bass NM, et al. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology 2004; 39: 230
12. Roayaie S, Schiano TD, Thung SN, et al. Results of retransplantation for recurrent hepatitis C. Hepatology 2003; 38: 1428
13. Neff GW, O'Brien CB, Nery J, et al. Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection. Liver Transpl 2004; 10: 1497
14. Bellido CB, Martinez JM, Gomez LM, et al. Indications for and survival after liver retransplantation. Transplant Proc 2010; 42: 637
15. DoyleHR,Morelli F,McMichaelJ, et al.Hepaticretransplantation-Ananalysis of risk factors associated with outcome. Transplantation 1996; 61: 1499
16. Azoulay D, Linhares MM, Huguet E, et al. Decision for retransplantation of the liver: An experience-and cost-based analysis. Ann Surg 2002; 236: 713
17. Wong T, Devlin J, Rolando N, et al. Clinical characteristics affecting the outcome of liver retransplantation. Transplantation 1997; 64: 878
18. Markmann JF, Gornbein J, Markowitz JS, et al. A simple model to estimate survival after retransplantation of the liver. Transplantation 1999; 67: 422
19. Rosen HR, Madden JP, Martin P. A model to predict survival following liver retransplantation. Hepatology 1999; 29: 365
20. Linhares MM, Azoulay D, Matos D, et al. Liver retransplantation: A model for determining long-term survival. Transplantation 2006; 81: 1016
21. Rosen HR, Prieto M, Casanovas-Taltavull T, et al. Validation and refinement of survival models for liver retransplantation. Hepatology 2003; 38: 460
22. Facciuto M, Heidt D, Guarrera J, et al. Retransplantation for late liver graft failure: Predictors of mortality. Liver Transpl 2000; 6: 174
23. Maluf DG, Edwards EB, Stravitz RT, et al. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients. Liver Transpl 2009; 15: 592
24. Gastaca M. Extended criteria donors in liver transplantation: Adapting donor quality and recipient. Transplant Proc 2009; 41: 975
25. Boin IF, Ataide EC, Leonardi MI, et al. Elderly donors for HCV(+) versus non-HCV recipients: Patient survival following liver transplantation. Transplant Proc 2008; 40: 792
26. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783
27. Markmann JF, Markowitz JS, Yersiz H, et al. Long-term survival after retransplantation of the liver. Ann Surg 1997; 226: 408
28. Ghabril M, Dickson R, Wiesner R. Improving outcomes of liver retransplantation: An analysis of trends and the impact of Hepatitis C infection. Am J Transplant 2008; 8: 404
29. Merion RM. 2006 SRTR Report on the State of Transplantation. American Journal of Transplantation 2007; 7 (Part 2); pp. 1317-1318
30. Akaike H. New look at the statistical model identification. IEEE Trans Autom Control 1974; 19: 716
31. Stone M. An asymptotic equivalence of choice of model by crossvalidation and Akaike's criterion. J R Stat Soc 1977; 39: 44
32. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361
33. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000; 56: 337.